Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiR‐92b‐3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy

1 Jan 2020

Abstract excerpt

Purpose. The current study aims to examine the effects of advanced glycation end products (AGEs) on the microRNA (miRNA) expression profile in the kidney tissues of rats. Methods. Wistar rats were randomly divided into three equal experiment groups: the AGE group, the RSA group, and the control group. The rats in the AGE group and the RSA group were administered with advanced glycation end products (AGEs) and rat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Chronic Kidney Disease and Diabetes
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32215042
DOI: 10.1155/2020/6050874

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiR‐92b‐3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic NephropathyPMID 32215042Read ↗

Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitusSemantic proximity Read ↗

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic NephropathySemantic proximity Read ↗

Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.Semantic proximity Read ↗

MicroRNAs and diabetic complications.Semantic proximity Read ↗

Expression and diagnostic value evaluation of urinary exosomal miR-142-3p in diabetic nephropathySemantic proximity Read ↗

MicroRNAs in Podocyte Injury in Diabetic NephropathySemantic proximity Read ↗

MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3Semantic proximity Read ↗

MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 DiabetesSemantic proximity Read ↗

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAsSemantic proximity Read ↗

Explore the possible pathway of improving liver and heart injury in diabetes nephropathy based on bioinformatics analysisSemantic proximity Read ↗

Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob MiceSemantic proximity Read ↗

TGF-Beta as a Master Regulator of Diabetic NephropathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.